S

Sapience Therapeutics, Inc.

21 employees

Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical
Biotechnology and Peptides

Date founded

2015

Funding rounds raised

Total raised

$41M

from 9 investors over 9 rounds

S

Sapience Therapeutics, Inc. raised $2M on May 4, 2023

Investors: NCI SBIR Development Center

S

Sapience Therapeutics, Inc. raised undisclosed on October 4, 2022

Investors: NCI SBIR Development Center

S

Sapience Therapeutics, Inc. raised $41M on May 31, 2022

Investors: Kingdon Capital Management, Eshelman Ventures, LLC and Bristol-Myers Squibb, UK

S

Sapience Therapeutics, Inc. raised undisclosed on May 18, 2021

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

S

Sapience Therapeutics, Inc. raised $23M on July 12, 2016

Investors: Eshelman Ventures, LLC, TaiAn Technologies Corporation and Celgene

FAQ